Back to search
FDAFDA · Food and drugs·Recall number D-0218-2025

Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, NDC 63459-910-11, Blister NDC 63459-910-12; (b)10 syringes in 1 CARTON, NDC 63459-910-15, Blister NDC 63459-910-12; (c) 1 syringe in 1 CARTON, NDC 63459-910-17 without safety guard and blister, Rx Only, Manufactured by: UAB Teva Baltics, Vilnius, Lithuania. Distributed by Teva Pharmaceuticals USA, Inc. North Wales PA 19454. Product of Israel.

Published February 12, 2025 · Recall initiated: January 10, 2025

Summary

FDA records drug Class II recall D-0218-2025, published February 12, 2025 and initiated January 10, 2025. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 34,636 cartons; Lot: Lot # (a) 135738, (b) 137149, (c) 137148, Exp. date 09/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit

What to do

Voluntary: Firm initiated · Letter

Get an email if GRANIX has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GRANIX
Manufacturer
Teva Pharmaceuticals USA, Inc
Distributor
Product was distributed nationwide.
Lot
Lot # (a) 135738, (b) 137149, (c) 137148, Exp. date 09/30/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, NDC 63459-910-11, Blister NDC 63459-910-12; (b)10 syringes in 1 CARTON, NDC 63459-910-15, Blister NDC 63459-910-12; (c) 1 syringe in 1 CARTON, NDC 63459-910-17 without safety guard and blister, Rx Only, Manufactured by: UAB Teva Baltics, Vilnius, Lithuania. Distributed by Teva Pharmaceuticals USA, Inc. North Wales PA 19454. Product of Israel. recalled?

Yes. FDA published recall D-0218-2025 on February 12, 2025. Reported hazard: Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GRANIX.